Unlock instant, AI-driven research and patent intelligence for your innovation.

Establishment of a composition for early diagnosis of ovarian cancer

An ovarian cancer and individual technology, which is applied in the determination/inspection of microorganisms, biochemical equipment and methods, instruments, etc., can solve the problems of low tumor burden, low abundance of ctDNA mutations, no mutation detection or missed detection, etc., to achieve Effects of Specificity and Sensitivity Improvement

Active Publication Date: 2022-05-20
上海允晟医学检验所有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, patients with early-stage ovarian cancer have a lower tumor burden, less cfDNA released into the blood, and a lower mutation abundance in ctDNA, requiring extremely sensitive techniques to detect
Although ctDNA-NGS sequencing technology is constantly improving, patients with early ovarian tumors still have no mutation detection or missed detection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Establishment of a composition for early diagnosis of ovarian cancer
  • Establishment of a composition for early diagnosis of ovarian cancer
  • Establishment of a composition for early diagnosis of ovarian cancer

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0097] The capture antibody can be prepared by linking a monoclonal antibody against the target biomarker to magnetic microparticles in the presence of a coupling solution under appropriate reaction conditions. Further, the detection antibody may be an alkaline phosphatase-labeled monoclonal antibody, an alkaline phosphatase-labeled monoclonal antibody, and combinations thereof.

[0098] As an embodiment of the protein chip of the present invention, the capture antibody is immobilized on microspheres carrying specific detectable signals (molecules) to prepare a liquid-phase protein chip. The principle of detection by using the liquid-phase protein chip is as follows: A single microsphere is passed through the detection channel, and the microsphere identification signal and detectable signal on the microsphere are simultaneously detected using two lasers. One type of laser excitation is the identification signal of the microspheres on the microspheres. According to the differen...

Embodiment 1

[0153] 1. Blood Sample Collection

[0154] Venous blood was collected using cell-free DNA blood collection tubes (LBgard blood collection tubes, Biomatirca, USA). blood cell, WBC) separation. All subjects underwent 10 mL whole blood sample collection. Plasma and peripheral blood samples were drawn before anesthesia on the day of surgery. The plasma of healthy volunteers in the biobank is stored at -80°C, no less than 3mL, and the storage time is within 2 years. It is transported to Shanghai Yunsheng Medical Laboratory by dry ice.

[0155] 2. Extraction of cfDNA and genomic DNA

[0156] Peripheral blood (10 mL for each newly collected sample, 3 mL for biobank samples) was centrifuged at 4° C., 1600 g for 10 minutes. The plasma (upper yellow layer) and leukocytes (middle layer) were collected, and then the upper plasma was centrifuged a second time to remove residual cells or cell debris at 4°C, 16000 g, 10 minutes. 0.5 mL of plasma was isolated and stored separately for su...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The present invention relates to the field of tumor diagnosis, and discloses the establishment of an early diagnosis composition for ovarian cancer. By measuring cfDNA content, cfDNA TP53 mutation abundance and CA125 protein expression level, ovarian cancer can be predicted, diagnosed and / or predicted Evaluation, its sensitivity, specificity and accuracy rate reached 91.11%, 94.34% and 93.38%, the detection rate of early ovarian cancer reached 78.9%. Using the marker combination and model scoring method of the present invention, among CA125-negative ovarian cancer patients, 71.05% of them can be detected, and among CA125-positive non-tumor populations, 74% of them can be correctly judged, It can well make up for the problems of missed and wrong detection of CA125. The present invention can provide clinically effective markers for early diagnosis or screening of ovarian cancer, and is beneficial to improving the prediction accuracy and detection rate of early ovarian cancer.

Description

technical field [0001] The present invention relates to the field of tumor diagnosis or screening, and relates to the establishment of a composition for early diagnosis of ovarian cancer, in particular to a combination of biological standards for ovarian cancer and its application, kit and evaluation model. Background technique [0002] The annual incidence of ovarian cancer ranks the third among female reproductive system tumors, showing an increasing trend year by year. The 5-year survival rate of patients with stage I ovarian cancer can exceed 90%, while the 5-year survival rate of advanced ovarian cancer is <20%. The ovaries are deep in the pelvis. When ovarian lesions are in the early stage, there are often no specific clinical symptoms, and when symptoms appear, 70% of the patients are already in the advanced stage. It can be seen that early screening and diagnosis of ovarian cancer is of great significance to its prognosis. [0003] Currently, clinically used met...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6886G01N33/574G16H50/30
CPCC12Q1/6886G01N33/57488G01N33/57449G16H50/30C12Q2600/106C12Q2600/118C12Q2600/156C12Q2600/158C12Q2600/178
Inventor 程晓东王芬芬李阳陈晓静陆伶佳
Owner 上海允晟医学检验所有限公司